| Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ... Frontiers in psychiatry 9, 622, 2018 | 216 | 2018 |
| Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model AF Chintoh, SW Mann, L Lam, A Giacca, P Fletcher, J Nobrega, ... Schizophrenia research 108 (1-3), 127-133, 2009 | 164 | 2009 |
| Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration PJ Fletcher, AF Chintoh, J Sinyard, GA Higgins Neuropsychopharmacology 29 (2), 308-318, 2004 | 151 | 2004 |
| Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration AF Chintoh, SW Mann, L Lam, C Lam, TA Cohn, PJ Fletcher, JN Nobrega, ... Journal of clinical psychopharmacology 28 (5), 494-499, 2008 | 128 | 2008 |
| The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment AT Raben, VS Marshe, A Chintoh, I Gorbovskaya, DJ Müller, MK Hahn Frontiers in neuroscience 11, 741, 2018 | 118 | 2018 |
| Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls MK Hahn, TMS Wolever, T Arenovich, C Teo, A Giacca, V Powell, ... Journal of clinical psychopharmacology 33 (6), 740-746, 2013 | 84 | 2013 |
| Antipsychotics and glucose metabolism: how brain and body collide C Kowalchuk, LN Castellani, A Chintoh, G Remington, A Giacca, ... American Journal of Physiology-Endocrinology and Metabolism 316 (1), E1-E15, 2019 | 82 | 2019 |
| Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model M Hahn, A Chintoh, A Giacca, L Xu, L Lam, S Mann, P Fletcher, ... Schizophrenia research 131 (1-3), 90-95, 2011 | 82 | 2011 |
| Insulin resistance following continuous, chronic olanzapine treatment: an animal model AF Chintoh, SW Mann, TKT Lam, A Giacca, G Remington Schizophrenia research 104 (1-3), 23-30, 2008 | 74 | 2008 |
| Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health N Stogios, A Gdanski, P Gerretsen, AF Chintoh, A Graff-Guerrero, TK Rajji, ... npj Schizophrenia 7 (1), 22, 2021 | 61 | 2021 |
| Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M A Chintoh, J Fulton, N Koziel, M Aziz, M Sud, JS Yeomans Pharmacology Biochemistry and Behavior 76 (1), 53-61, 2003 | 57 | 2003 |
| Delusions and processing of discrepant information: an event-related brain potential study JB Debruille, N Kumar, D Saheb, A Chintoh, D Gharghi, C Lionnet, S King Schizophrenia Research 89 (1-3), 261-277, 2007 | 54 | 2007 |
| The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy KA Costa-Dookhan, SM Agarwal, A Chintoh, VN Tran, N Stogios, ... Expert opinion on drug safety 19 (1), 43-57, 2020 | 50 | 2020 |
| Effects of 5-HT depletion in the frontal cortex or nucleus accumbens on response inhibition measured in the 5-choice serial reaction time test and on a DRL schedule PJ Fletcher, JW Chambers, Z Rizos, AF Chintoh Behavioural brain research 201 (1), 88-98, 2009 | 47 | 2009 |
| Atypical antipsychotics and effects on feeding: from mice to men L Benarroch, C Kowalchuk, V Wilson, C Teo, M Guenette, A Chintoh, ... Psychopharmacology 233, 2629-2653, 2016 | 43 | 2016 |
| In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact C Kowalchuk, C Teo, V Wilson, A Chintoh, L Lam, SM Agarwal, A Giacca, ... Journal of Psychiatry and Neuroscience 42 (6), 424-431, 2017 | 39 | 2017 |
| Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: an animal model MD Guenette, A Giacca, M Hahn, C Teo, L Lam, A Chintoh, T Arenovich, ... Schizophrenia research 146 (1-3), 162-169, 2013 | 37 | 2013 |
| Metformin attenuates olanzapine-induced hepatic, but not peripheral insulin resistance GJ Remington, C Teo, V Wilson, A Chintoh, M Guenette, Z Ahsan, ... J. Endocrinol 227 (2), 71-81, 2015 | 35 | 2015 |
| Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition S Mann, A Chintoh, A Giacca, P Fletcher, J Nobrega, M Hahn, ... Pharmacology Biochemistry and Behavior 103 (4), 717-722, 2013 | 34 | 2013 |
| Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial SM Agarwal, R Panda, KA Costa-Dookhan, NE MacKenzie, QC Treen, ... Translational Psychiatry 11 (1), 219, 2021 | 30 | 2021 |
